1. ¹Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University of Munich, Munich, Germany
2. ²Tor Vergata University, IRCCS Santa Lucia, Rome, Italy

Correspondence: Dr R Rupprecht, Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University of Munich, Nussbaumstrasse 7, D-80336 Munich, Germany. Tel: +49 89 5160 2770; Fax: +49 89 5160 5524; E-mail: Rainer.Rupprecht@med.uni-muenchen.de

Received 7 July 2004; Revised 7 December 2004; Accepted 15 December 2004; Published online 9 February 2005.

Abstract

There is evidence that both cerebrospinal fluid (CSF) and plasma concentrations of 3-reduced neuroactive steroids are decreased in major depressive disorder. Successful antidepressant pharmacotherapy, for example, with selective serotonin reuptake inhibitors (SSRIs), over several weeks is accompanied by an increase in CSF and plasma concentrations of these neuroactive steroids. However, no such increase has been observed during nonpharmacological treatments such as partial sleep deprivation or repetitive transcranial magnetic stimulation. In order to investigate whether concentration changes in neuroactive steroids are an important component of clinically effective antidepressant treatment, we examined plasma concentrations of the neuroactive steroids 3,5-tetrahydroprogesterone, 3,5-tetrahydroprogesterone, 3,5-tetrahydroprogesterone, and their precursors progesterone, 5-dihydroprogesterone, and 5-dihydroprogesterone in 31 pharmacotherapy-resistant depressed in-patients before and after unilateral electroconvulsive therapy (ECT) as a monotherapy over 4 weeks. Samples were quantified for neuroactive steroids by means of a highly sensitive and specific combined gas chromatography/mass spectrometry analysis. In all, 51.6% of the patients were treatment responders. There was no influence of ECT on the plasma concentrations of any neuroactive steroid studied. Moreover, neuroactive steroid levels did not differ between treatment responders and nonresponders. Our study shows that changes in neuroactive steroid plasma levels are not a mandatory factor for successful antidepressant treatment by ECT. Thus, the previously observed changes in plasma concentrations of neuroactive steroids following treatment with antidepressants such as SSRIs more likely reflect distinct pharmacological properties of these compounds rather than clinical improvement.